TORL (UCLA), UCLA Technology Development Group
TORL (UCLA), UCLA Technology Development Group is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE)
Sponsor Novartis Pharma AG
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for TORL (UCLA), UCLA Technology Development Group?
The 2026-10-09 snapshot links TORL (UCLA), UCLA Technology Development Group to 1 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for TORL (UCLA), UCLA Technology Development Group?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to TORL (UCLA), UCLA Technology Development Group conducted?
The linked trials record locations in 10 countries, including Austria, Belgium, Germany, Spain, France. These are trial locations, not confirmed office locations or countries where TORL (UCLA), UCLA Technology Development Group delivered services.
What can this page tell me about TORL (UCLA), UCLA Technology Development Group's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under TORL (UCLA), UCLA Technology Development Group. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- TORL (UCLA), UCLA Technology Development Group